Sanofi CDR (CAD Hedged) (SNY : TSX)
Common Stock
$42.51
CAD
+23.22 (120.37%)
Last updated: 2026-09-22
Follow SNY
SNY
Sanofi CDR (CAD Hedged)
WealthAwesomePerformance
1 Day
-0.10%
1 Week
+1.42%
1 Month
-5.63%
YTD
-9.57%
Key Statistics
Market Cap
$96.26B
52W High
$21.67
52W Low
$18.78
P/E Ratio
3.72
50 Day MA
$19.73
200 Day MA
$20.32
Beta
-
Dividend Yield
21.44%
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/22/2026 | $19.20 | $19.27 | $19.20 | $19.27 | $19.27 | 1,550 |
| 9/21/2026 | $19.37 | $19.37 | $19.29 | $19.29 | $19.29 | 321 |
| 9/18/2026 | $19.20 | $19.20 | $19.20 | $19.20 | $19.20 | 103 |
| 9/17/2026 | $19.34 | $19.34 | $19.34 | $19.34 | $19.34 | 530 |
| 9/16/2026 | $19.16 | $19.28 | $19.16 | $19.24 | $19.24 | 1,100 |
| 9/11/2026 | $19.00 | $19.00 | $19.00 | $19.00 | $19.00 | 410 |
| 9/10/2026 | $19.06 | $19.06 | $19.06 | $19.06 | $19.06 | 1,000 |
| 9/9/2026 | $19.16 | $19.16 | $19.14 | $19.14 | $19.14 | 1,522 |
| 9/8/2026 | $19.37 | $19.46 | $19.32 | $19.38 | $19.38 | 2,270 |
| 9/4/2026 | $19.85 | $19.85 | $19.85 | $19.85 | $19.85 | 125 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on SNY's historical volatility
30-Day Vol
17.6%
Annualized
90-Day Vol
29.0%
Annualized
Trend (90d)
-7.6%
Annualized drift
90d Mean
C$18.76
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$19.10 | C$17.97 – C$20.29 |
| 60 trading days | C$18.93 | C$17.37 – C$20.63 |
| 90 trading days | C$18.76 | C$16.88 – C$20.84 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Sanofi CDR (CAD Hedged)
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Innate Pharma SA for a natural killer cell engager program targeting B7-H3; and Blackstone Life Sciences to develop pivotal studies and clinical development program. Further, it has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop novel targeted protein degradation therapies; Denali Therapeutics Inc. to treat a range of systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for the discovery and development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab, as well as a strategic alliance with the Department of Health " Abu Dhabi for the development of global vaccines. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Financials
- Revenue (TTM)
- $0
- EBITDA
- -
- Profit Margin
- 0.00%
- ROE (TTM)
- 663.47%
- EPS (Diluted)
- 0.00
- Book Value
- -
Classification
- Sector
- Health Care
Recent Dividends
$0.7979CAD
Ex: May 6, 2026
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About SNY
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| MNO | Meridian Mining UK Societas | $2.30 | +22.99% |
| PYR | PyroGenesis Canada Inc. | $0.23 | +17.50% |
| CJR-B | Corus Entertainment Inc | $0.04 | +16.67% |
| ITH | International Tower Hill Mines Ltd | $4.18 | +13.90% |
| CURA | Curaleaf Holdings Inc. | $16.36 | +11.29% |
| SLT | Saltire Capital Ltd. | $3.50 | +11.11% |
| SLT-U | Saltire Capital Ltd. | $2.52 | +10.53% |
| AUMN | Golden Minerals Company | $0.32 | +10.34% |